ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Study of Plozasiran in Adults With Severe Hypertriglyceridemia

ClinicalTrials.gov ID: NCT06347016

Public ClinicalTrials.gov record NCT06347016. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 1:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Plozsiran in Adults With Severe Hypertriglyceridemia

Study identification

NCT ID
NCT06347016
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Arrowhead Pharmaceuticals
Industry
Enrollment
311 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • Plozasiran Injection Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 22, 2024
Primary completion
May 31, 2026
Completion
Aug 31, 2026
Last update posted
Oct 23, 2025

2024 – 2026

United States locations

U.S. sites
50
U.S. states
21
U.S. cities
47
Facility City State ZIP Site status
Research Site 1 Birmingham Alabama 35205
Research Site 2 Mobile Alabama 36604
Research Site 3 Beverly Hills California 90211
Research Site 4 Canoga Park California 91303
Research Site 5 Huntington Beach California 92648
Research Site 6 Lincoln California 95648
Research Site 7 Long Beach California 90822
Research Site 8 Oxnard California 93030
Research Site 9 Clearwater Florida 33756
Research Site 10 North Miami Florida 33162
Research Site 11 Sarasota Florida 34239
Research Site 12 Lawrenceville Georgia 30044
Research Site 13 Sugar Hill Georgia 30518
Research Site 14 Elkhart Indiana 46514
Research Site 15 Indianapolis Indiana 46290
Research Site 16 South Bend Indiana 46617
Research Site 17 Overland Park Kansas 66211
Research Site 18 Topeka Kansas 66606
Research Site 19 Metairie Louisiana 70001
Research Site 20 Annapolis Maryland 21401
Research Site 21 Jackson Mississippi 39202
Research Site 22 Fremont Nebraska 68025
Research Site 23 Norfolk Nebraska 68701
Research Site 24 Morristown New Jersey 07960
Research Site 26 New York New York 10029
Research Site 27 Riverhead New York 11901
Research Site 25 The Bronx New York 10461
Research Site 28 Asheboro North Carolina 27203
Research Site 29 Wilmington North Carolina 28412
Research Site 30 Beavercreek Ohio 45431
Research Site 31 Columbus Ohio 43214
Research Site 32 Oklahoma City Oklahoma 73112
Research Site 33 Horsham Pennsylvania 19044
Research Site 34 Newport Pennsylvania 17074
Research Site 35 Philadelphia Pennsylvania 19104
Research Site 36 Philadelphia Pennsylvania 19104
Research Site 37 Fort Mill South Carolina 29707
Research Site 38 Greenville South Carolina 29607
Research Site 39 Chattanooga Tennessee 37411
Research Site 40 Fort Worth Texas 76132
Research Site 41 Houston Texas 77040
Research Site 42 Houston Texas 77090
Research Site 43 Houston Texas 77090
Research Site 44 Sugar Land Texas 77479
Research Site 45 Tomball Texas 77375
Research Site 46 Victoria Texas 77901
Research Site 47 Bountiful Utah 84010
Research Site 48 St. George Utah 84790
Research Site 49 Manassas Virginia 20110
Research Site 50 Roanoke Virginia 24014

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 99 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06347016, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 23, 2025 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06347016 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →